A phase II study for metabolic in vivo response monitoring with sequential .sup.18.sup.FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
In: BMC Cancer, Jg. 12 (2012-03-22), S. 108
Online
academicJournal
Zugriff:
Titel: |
A phase II study for metabolic in vivo response monitoring with sequential .sup.18.sup.FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
|
---|---|
Autor/in / Beteiligte Person: | Berger, Anne Katrin ; von Gall, Carl ; Abel, Ulrich ; Delorme, Stefan ; Kloor, Matthias ; Ose, Jennifer ; Weber, Tim Frederik ; Stange, Annika ; Haag, Georg Martin ; Haberkorn, Uwe ; Lordick, Florian ; Jäger, Dirk |
Link: | |
Zeitschrift: | BMC Cancer, Jg. 12 (2012-03-22), S. 108 |
Veröffentlichung: | 2012 |
Medientyp: | academicJournal |
ISSN: | 1471-2407 (print) |
DOI: | 10.1186/1471-2407-12-108 |
Sonstiges: |
|